Predictors of Post-alteplase Hemorrhagic Transformation of Brain Infarction
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 600 participants.
Also called NCT06337175
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 600 participants
- Sponsor
- Registry
-
NCT06337175
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Egypt
- Registry status
- Completed
Technical summary
Registry record NCT06337175. Non-randomized; no masking; primary purpose treatment. Start 2021-06-01 (actual); primary completion 2023-10-30 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Predictors of Post-alteplase Hemorrhagic Transformation of Brain Infarction
- Condition
- Ischemic Stroke
- Condition
- Alteplase Adverse Reaction
- Intervention (Drug)
- Alteplase
- Intervention (Drug)
- Alteplase
- Lead sponsor
- Kafrelsheikh University
Record details
- Record id
cardio:ct-nct06337175- Content hash
403f4934f27ffbe51a41dca919ef9d31eb41e4f5a1e54ab9313efaf59ad4bd32